Elation Health integrated Surescripts’ real-time prescription benefit tool — which gives clinicians immediate access to patient-specific medication coverage and cost data — into its EHR. The partnership aims to improve patients' medication adherence by helping primary care physicians have more meaningful conversations with their patients about prescription affordability during visits.
In an interview, Surescripts’ Clinical Product Advisor Cecelia Byers shared how the company is working to simplify prescribing and obtaining specialty medications.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Integrating pharmacists into primary care teams could be a key way to address the primary care physician shortage, according to a new report. The pandemic made it clear that pharmacists are clinically trained and want to provide care beyond filling prescriptions, the report said.
Panelists at a recent healthcare conference expressed optimism about the automation technology that health plans, pharmacy benefit managers and providers can adopt to facilitate real-time data sharing. They said that such technology has potential to improve medication adherence, reduce costs and save time for both providers and payers.
MedCity News interviewed CEOs of public companies, entrepreneurs, VCs and payers at the HLTH conference that concluded last week. They had a range of answers to the question. But one common theme emerged: Currently, everyone has a vise-like grip on expenditure.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Register to view a webinar, sponsored by Surescripts, highlighting progress made on interoperability and what's needed to improve and expand it.
A webinar, sponsored by Surescripts on April 28, will include: Surescripts CEO Tom Skelton, Epic CEO Judy Faulkner, Healthcare Leadership Council President Mary Grealy, and UC San Francisco Assistant Professor of Medicine A. Jay Holmgren. Register today!
Several pharmacies signed a letter asking Surescripts’ board to rescind its deal with GoodRx. They said the deal would not reveal the true cost of medications, and might steer patients away from independent pharmacies.
The agreement would provide prescribing healthcare providers with information in their EMR about GoodRx's cash discount pricing for patients who are uninsured or where insurance pricing isn't available.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
More doctors are using a drug cost tool created by SureScripts than ever before underscoring that price transparency tools that show drugs requiring prior authorization can lead clinicians to switch the drugs they prescribe.
Surescripts says that instead of using its own National Provider Identification (NPI) number, Pillpack fraudulently used NPIs that was associated with random healthcare providers.
CNBC cited unnamed sources who state that PillPack will be blocked from accessing data about a patient's list of medications and prescription history, which it uses to accurately and safely send out medications to customers.
Beginning next month, Cerner customers will start implementing Surescripts' Real-Time Prescription Benefit tool into their Millennium EHRs. The Kansas City vendor's collaboration with Surescripts was initially announced last November.
By joining forces with pharmacy benefit managers like Express Scripts and EHR vendors such as Epic and Cerner, Surescripts is working to improve price transparency in the prescribing process.